Angiographic progression of coronary artery disease in patients with end-stage renal disease

被引:49
作者
Gradaus, F
Ivens, K
Peter, AJ
Heering, P
Schoebel, FC
Grabensee, B
Strauer, BE
机构
[1] Univ Dusseldorf, Klin Kardiol Pneumol & Angiol, D-40225 Dusseldorf, Germany
[2] Univ Dusseldorf, Klin Nephrol & Rheumatol, D-40225 Dusseldorf, Germany
关键词
angiography; coronary artery disease; cardiovascular mortality; end-stage renal disease; morphological progression;
D O I
10.1093/ndt/16.6.1198
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Patients with end-stage renal disease have an increased risk of developing coronary artery disease (CAD). The cardiovascular mortality of dialysis patients is 10-15 times higher compared with the general population. The aim of our study was to evaluate the morphological progression of coronary arteriosclerosis in this cardiovascular high-risk group by visual assessment and quantitative coronary angiography. Methods and results. In 26 patients with chronic renal failure (age. 47+/-11 years: 15 male: duration of dialysis, 23 +/- 25 months) the severity of CAD and degree of coronary stenoses were assessed in two coronary angiograms after a mean follow-up interval of 30 +/- 15 months (12-60). Baseline angiography revealed CAD in 13/22 patients (59%). The second angiography was performed as screening procedure prior to renal transplantation (n=20) and/or as follow-up angiography after coronary angioplasty (n = 10). Visual assessment showed a progression defined by the development of haemodynamically relevant stenosis of > 50% luminal diameter in 13 patients. Quantitative angiographic evaluation was performed in a total of 45 segments showing >25% narrowing at the second angiogram. A progression (>15% luminal reduction) was found in 17 of 45 segments, a new lesion (initial luminal diameter < 20%) was detected in nine segments, resulting in progression or new lesion in 16 patients (62%). Patients with or without progression did not differ in age. duration of dialysis treatment, number of cardiovascular risk factors, or serum total cholesterol and fibrinogen levels. After percutaneous transluminal coronary angioplasty (PTCA) a restenosis was seen in seven of 16 primarily successfully dilated segments. After the second angiography, myocardial revascularization was performed in eight patients (1 PTCA, 7 coronary artery bypass graft). Conclusions, Patients with end-stage renal disease have a high prevalence of CAD. In line with the clinical course, CAD patients on maintenance dialysis undergo rapid angiographic progression of CAD, which results in a high rate of subsequent myocardial revascularizations.
引用
收藏
页码:1198 / 1202
页数:5
相关论文
共 27 条
[1]   COMPLICATIONS AND LONG-TERM OUTCOME AFTER PERCUTANEOUS CORONARY ANGIOPLASTY IN CHRONIC-HEMODIALYSIS PATIENTS [J].
AHMED, WH ;
SHUBROOKS, SJ ;
GIBSON, CM ;
BAIM, DS ;
BITTL, JA .
AMERICAN HEART JOURNAL, 1994, 128 (02) :252-255
[2]  
AKERS S, 1998, INT UROL NEPHROL, V6, P777
[3]   LIPID ABNORMALITIES IN RENAL-DISEASE [J].
APPEL, G ;
SCHAEFER, E ;
MADIAS, NE ;
MADAIO, MP ;
HARRINGTON, JT ;
LEVEY, AS ;
NARAYAN, G ;
MEYER, K .
KIDNEY INTERNATIONAL, 1991, 39 (01) :169-183
[4]   Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: A matched case-control study [J].
Bostom, AG ;
Shemin, D ;
Lapane, KL ;
Sutherland, P ;
Nadeau, MR ;
Wilson, PWF ;
Yoburn, D ;
Bausserman, L ;
Tofler, G ;
Jacques, PF ;
Selhub, J ;
Rosenberg, IH .
ATHEROSCLEROSIS, 1996, 125 (01) :91-101
[5]   COMPARATIVE MORTALITY FROM CARDIOVASCULAR-DISEASE IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
BROWN, JH ;
HUNT, LP ;
VITES, NP ;
SHORT, CD ;
GOKAL, R ;
MALLICK, NP .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (08) :1136-1142
[6]   THE DYNAMICS OF PROGRESSION OF CORONARY ATHEROSCLEROSIS STUDIED IN 168 MEDICALLY TREATED PATIENTS WHO UNDERWENT CORONARY ARTERIOGRAPHY 3 TIMES [J].
BRUSCHKE, AVG ;
KRAMER, JR ;
BAL, ET ;
HAQUE, IU ;
DETRANO, RC ;
GOORMASTIC, M .
AMERICAN HEART JOURNAL, 1989, 117 (02) :296-305
[7]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[8]   LIPOPROTEIN(A) IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR-DISEASE IN HEMODIALYSIS-PATIENTS [J].
CRESSMAN, MD ;
HEYKA, RJ ;
PAGANINI, EP ;
ONEIL, J ;
SKIBINSKI, CI ;
HOFF, HF .
CIRCULATION, 1992, 86 (02) :475-482
[9]   INCREASED CARDIOVASCULAR RISK-FACTORS AND FEATURES OF ENDOTHELIAL ACTIVATION AND DYSFUNCTION IN DIALYZED UREMIC PATIENTS [J].
GRIS, JC ;
BRANGER, B ;
VECINA, F ;
ALSABADANI, B ;
FOURCADE, J ;
SCHVED, JF .
KIDNEY INTERNATIONAL, 1994, 46 (03) :807-813
[10]  
HARRIS M, 1979, DIABETES, V28, P1039